A technician works at a manufacturing facility of Chinese vaccine maker CanSino Biologics in Tianjin, China. Photo: Reuters/China OutA technician works at a manufacturing facility of Chinese vaccine maker CanSino Biologics in Tianjin, China. Photo: Reuters/China Out
A technician works at a manufacturing facility of Chinese vaccine maker CanSino Biologics in Tianjin, China. Photo: Reuters/China Out

CanSino, China’s first drug maker to start human trials for Covid-19 vaccine, soars in Star Market trading debut

  • Pharmaceutical giant is first Chinese company to test a Covid-19 vaccine on humans
  • Will use funds to build manufacturing base, grow Covid-19 vaccine research

Topic |   China stock market: Latest news and updates
A technician works at a manufacturing facility of Chinese vaccine maker CanSino Biologics in Tianjin, China. Photo: Reuters/China OutA technician works at a manufacturing facility of Chinese vaccine maker CanSino Biologics in Tianjin, China. Photo: Reuters/China Out
A technician works at a manufacturing facility of Chinese vaccine maker CanSino Biologics in Tianjin, China. Photo: Reuters/China Out
READ FULL ARTICLE
Close
We need your support

Advertising helps us continue to provide quality content. Help support us by disabling your adblocker on our site.

How to whitelist us:
  1. 1
    Click on the AdBlock icon at the top right corner of your browser.
    For iOS, go to Settings/Safari/Content Blockers and turn it off.

    For Android, go to your Ad blocker app/Settings and turn it off.
  2. 2
    Click Enabled on this site until the text reads Disabled on this site.
  3. 2
    Click the cross icon on the top right corner to close this window and refresh the page.
  4. 3
    Click the cross icon on the top right corner to close this window and refresh the page.